AZAMIAN BOBAK R. (President and CEO) sold 1.2% of their position (10K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $800.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/3/2026ACC: 0001827672-26-000011
DirectorOfficer10% Owner· President and CEO
Since Oct 2020
-10K
Net shares
Net seller
$800.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−10K
Price / share
$80.06
Trade value
$800.60K
% of position
1.2%
9/2/2026
847.99K→837.99K
Total
Net shares
−10K
Net value
-$800.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/2/2026 | S · Sale | −10K | $80.06 | $800.60K | 1.2% | 847.99K | 837.99K |
| Total | −10K | -$800.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned33.42K
Total
33.42K direct33.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 33.42K | Direct |
| Total | 33.42K | 33.42K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported